Abstract
Urachal cancer is a rare and aggressive cancer that often presents in advanced stages. Given the rarity of this malignancy, medical case studies provide one of the few sources of literature available through which clinicians can guide medical management. Surgery is widely considered to be the mainstay of therapy when disease is localised and surgically resectable, therefore most current case studies on urachal cancer focus on surgical management, occasionally with adjuvant chemotherapy. However, few case studies discuss chemotherapy alone in the treatment of metastatic disease. Most studies indicate a median overall survival between 12 and 24 months for metastatic urachal adenocarcinoma. Bone marrow metastasis of solid tumours, when considered alone, portends a poor prognosis. The patient in this case study represents a rare case of stage IV urachal adenocarcinoma metastatic to the bone marrow without progression of disease after 6 months of treatment.
Reference24 articles.
1. Urachal adenocarcinoma;Varma;Appl Radiol,2019
2. Urachal Remnant Diseases: Spectrum of CT and US Findings
3. Malignant transformation of a urachal cyst-a case report and literature review;Rhudd;J Surg Case Rep,2018
4. Goljan EF . Chapter 21: Lower urinary tract and male reproductive disorders. In: Goljan EF , ed. Rapid review pathology. 528. 4 edn. Elsevier, 2014.
5. Urachal tumor: a case report of an extremely rare carcinoma;Palla Garcia;Case Rep Pathol,2017
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献